Quanterix Corporation
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG0027NWC69
QTRX
Quanterix Corporation
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Medical Devices
NAME
Quanterix Corporation
ISIN
US74766Q1013
TICKER
QTRX
MIC
XNAS
REUTERS
QTRX.OQ
BLOOMBERG
QTRX US
F&G:
75
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Fri, 11.07.2025
Quanterix
US74766Q1013
Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that on July 8, 2025, the Company approved inducement grants of restricted stock units (“RSUs”) representing 267,269 shares of Quanterix common stock to twenty employees newly-hire...
Quanterix
Tue, 08.07.2025
Quanterix
US74766Q1013
Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology an...
Quanterix
Mon, 23.06.2025
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea through its regional distribution partner, HS Biosystems.
...
Quanterix
Fri, 06.06.2025
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami, Florida on Monday, June 9th, at 1:20 p.m. ET. Quanterix will also host...
Quanterix
Mon, 12.05.2025
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the first quarter ended March 31, 2025.
"During a time when market resource constraints threaten to slow scientific progress, we remain committed to keeping the innovation engine moving fo...
Quanterix
Mon, 05.05.2025
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, May 12, 2025, at 4:30 p.m. E.T., to discuss its first quarter 2025 financial results.
Quanterix will issue a press release regarding its first quarter 2025 financia...
Quanterix
Wed, 30.04.2025
Quanterix
US74766Q1013
Kent Lake PR LLC (“Kent Lake”), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), today issued the following statement regarding the Company’s announcement of an amended merger agreement (the “Amended Merger Agreement”) related to its proposed merger (the “Merger”...
Quanterix
Tue, 29.04.2025
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement.
Under the amended terms, Quanterix will issue approximately 7.76 mil...
Quanterix
Thu, 17.04.2025
Quanterix
US74766Q1013
Kent Lake PR LLC (“Kent Lake”), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission (the “SEC”) and sent a letter to its fellow Quanterix shareholders in ...
Quanterix
Mon, 07.04.2025
Quanterix
US74766Q1013
Kent Lake PR LLC (“Kent Lake”) is a holder of approximately 7.5% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX). Today, Kent Lake issued a statement related to recent disclosures indicating that Quanterix has officially entered into a Securities Purchase Agreement under which Akoya Bioscience...
Quanterix
Information on product placements
BARRISTA SMART * AD
P R O D U C T S U G G E S T I O N S
